| Application no. and date | 13770771.7 (espacenet) (Federated) (European Patent Register), 20130918 | | Patent/reg. no. and date | DK/EP 2897644, 20180606 | | Publication date | 20150729 | | Priority no. and date | US 201261703533 P, 20120920, US 201261708070 P, 20121001 | | EP pub. no. and date |
EP 2897644 20150729 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157461 | | Inventor | HUANG, Xizhong, c/o Novartis Institutes for BioMedical
Research Inc.
250 Massachusetts Avenue
Cambridge
Massachusetts 02139, US,
GOLDBRUNNER, Michael, c/o Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4184 (2006.01) , A61K 31/4196 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/445 (2006.01) , A61K 31/566 (2006.01) , A61K 31/5685 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutisk kombination omfattende en phosphatidylinositol-3-kinase-inhibitor og en aromatase-inhibitor | | Int. application no. | US2013060292 | | Int. publication no. | WO2014047109 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
